课题基金 / 基金详情

Development of a Gal-free Calcification Resistant Porcine Pericardial Heart Valve.

Development of a Gal-free Calcification Resistant Porcine Pericardial Heart Valve.
无加仑抗钙化猪心包心脏瓣膜的开发。
批准号:
MR/L013193/1
负责人:
Christopher Mcgregor
金额:
$65.15万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2014
资助国家:
英国
项目状态:
已结题
起止时间:
2014 至 --

项目摘要

项目成果

Christopher Mcgregor的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
There are valves in the heart which work to control the normal flow of blood. These valves may be damaged because of birth defects, old age, or after repeated infection with rheumatic fever. If left untreated this is a life threatening condition. There are about 500,000 surgeries to repair or replace heart valves each year. Replacement valves are either mechanical, made of plastic and metal, or biological, made of non-living tissue generally obtained from pigs or cows. Patients and doctors prefer biological heart valves (BHVs) because they work for a long time in older patients, the most frequent group, and do not require daily use of blood thinners which must be used with mechanical valves. In younger adults (30 - 50 years) and in children BHVs wear out rapidly, often within 5 years. These BHVs fail because they build up bone-like deposits of calcium which weaken the valve, leading to tears, or obstruct blood flow because they block the opening of the valve. Scientist and commercial valve companies have long sought to produce BHVs which do not calcify because these could be used in younger patients without the need for blood thinners. So far the calcification blocking treatments which have been developed have been able to greatly reduce valve calcification, when they are tested in animals, but have not been able stop calcification or broaden the use of BHV in younger adults. We have identified an immune driven inflammation which accelerates calcification of biological heart valve materials. This inflammation is unique to humans because a portion of their immune system reacts with a substance, called Gal, not made by people but commonly made in animals and present on the BHV. To block this immune inflammation we have genetically altered pigs so they no longer make Gal and have shown that this Gal-free tissue has a reduced rate of calcification. These Gal knockout pigs are healthy and normal. This project is designed to compare the mechanical function of BHVs made from normal pig tissue with the function of BHVs made from Gal-free tissue. Successfully performing these test which are required by British standards, is the first forward to making a new BHV which resists calcification and may be useful in younger patients
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
Initial validation of Gal knockout pig tissues as materials for biological heart valves
Gal基因敲除猪组织作为生物心脏瓣膜材料的初步验证
DOI: --
发表时间: 2019
期刊: XENOTRANSPLANTATION
影响因子: 3.9
作者: [McGregor Christopher]
通讯作者: McGregor Christopher
Physical equivalency of wild type and galactose α 1,3 galactose free porcine pericardium; a new source material for bioprosthetic heart valves.
野生型和半乳糖α 1,3 半乳糖游离猪心包的物理等效性;生物人工心脏瓣膜的新原料。
DOI: 10.1016/j.actbio.2016.06.007
发表时间: 2016-09-01
期刊: Acta biomaterialia
影响因子: 9.7
作者: [McGregor C, Byrne G, Rahmani B, Chisari E, Kyriakopoulou K, Burriesci G]
通讯作者: Burriesci G
DOI: 10.1111/xen.12198
发表时间: 2015-11
期刊: XENOTRANSPLANTATION
影响因子: 3.9
作者: [Lin, Yi, Miyagi, Naoto, Byrne, Guerard W., Du, Zeji, Kogelberg, Heide, Gazi, Mozammel H., Tazelaar, Henry D., Wang, Chunsheng, McGregor, Christopher G. A.]
通讯作者: McGregor, Christopher G. A.
DOI: 10.1111/xen.12411
发表时间: 2018-05
期刊: Xenotransplantation
影响因子: 3.9
作者: [Byrne GW]
通讯作者: Byrne GW
6
    Development of a Gal-free Calcification Resistant Porcine Pericardial Heart Valve
    • 批准号:
      MC_PC_21007
    • 项目类别:
      Intramural
    • 资助金额:
      $8.59万
    • 财政年份:
      2021
    • 负责人:
      Christopher Mcgregor
    • 依托单位:
    Development of a Gal-free Calcification Resistant Porcine Pericardial Heart Valve: Establishment of Biological Tissue Equivalence.
    • 批准号:
      MR/R006393/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $173.14万
    • 财政年份:
      2018
    • 负责人:
      Christopher Mcgregor
    • 依托单位:
    国内基金
    海外基金
    靶向Gal-1提高肝内胆管癌T细胞功能及增敏PD-1免疫治疗的机制研究
    FTO介导GAL3的N6-甲基腺苷修饰调节瘢痕疙瘩发生的机制研究
    • 批准号:
      JCZRLH202600632
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    Gal-3介导肿瘤免疫逃逸促进结直肠癌转 移的分子机制及干预研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2025
    • 负责人:
      王金祥
    • 依托单位:
    Gal9+TAMs经旁分泌塑造新型Gal9-Met互作轴驱动肝癌免疫逃逸的分子机制及干预策略
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      杨文静
    • 依托单位: